Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 589 clinical trials
None

  • None views
None

  • None views
None

  • None views
None

  • None views
Genetic Characteristics of Metastatic Breast Cancer Patients

  • At disease progression after 1st line treatment for MBC, blood sample (20cc) will be obtained (tissue; optional)
    • ul>

    (2) WES, RNASeq, ctDNA, Exosome

    <ul>
  • We will analyze genomic characteritics using WES, RNASeq, ctDNA, Exosome.
    • ul>

    stage iv breast cancer
    cancer
    breast cancer
    • 0 views
    • 19 Feb, 2024
    • 1 location
    Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

    ul>

    Secondary Objectives:

    <ul>
  • Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates.

    • diphenhydramine
    kidney transplant
    isatuximab
    nephropathy
    sar650984
    • 0 views
    • 19 Feb, 2024
    • 2 locations
    MTD Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors

    ul>

    • 0 views
    • 19 Feb, 2024
    • 1 location
    Cervical Ripening Balloons for Same-Day Cervical Prep (CRB)

  • How acceptable is cervical preparation with cervical ripening balloon for same-day outpatient D&E?
    • ul>

    Participants will:

    <ul>
  • Have cervical preparation with cervical ripening balloon (experimental group) or osmotic dilators (usual care group)
  • Complete two surveys, one about the cervical preparation and one about the D&E procedure
    • ul>

    • 0 views
    • 12 May, 2025
    • 1 location
    Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor Copanlisib Given in Combination With the Immunotherapeutic Agents Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

    Patients with relapsed or refractory follicular or marginal zone lymphoma who have received at least one prior line of therapy will receive

    <ul>
  • Copanlisib IV: day 1, 8, 15 every 28 days
  • Nivolumab IV: Cycle 1 days 1 and 15; then day 1 only
  • Rituximab IV: Cycle 1 days …

    alcoholic cirrhosis
    pulmonary disease
    attenuated vaccines
    pneumonia
    prednisone
    • 0 views
    • 19 Feb, 2024
    • 1 location
    Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19

    Objectives :

    Primary objective:

    To describe the lung ultrasound lesions in pregnant women in case of suspected or confirmed COVID-19

    Secondary objectives:

    <ul>
  • To compare the lung ultrasound lesions with chest Computed Tomography -scanner (CT-Scan) lesions
  • To evaluate the performances of …

    • 0 views
    • 19 Feb, 2024
    • 1 location